🔬

Research-Backed Natural Remedies

Every remedy listed here is supported by peer-reviewed clinical trials, systematic reviews, or Cochrane meta-analyses. We include real citations so you can read the evidence yourself.

⚕️ Educational only — not medical advice. Always consult a qualified healthcare provider before starting any supplement or practice.
📚 19 remedies in library
🤔

Ask About Any Remedy

Ask whether a specific natural remedy has clinical research backing. If it passes our evidence standard and isn't in the library yet, it'll be added automatically.

● Strong Evidence Multiple RCTs or Cochrane meta-analysis
● Moderate Evidence Consistent but smaller or heterogeneous trials
🌸

Echinacea

Cochrane review: modest reduction in cold incidence and duration

Moderate Evidence

Echinacea preparations (particularly E. purpurea extracts) have been tested in dozens of RCTs. A Cochrane review of 24 trials concluded certain echinacea preparations may prevent colds (relative risk reduction ~10–58% across studies) and reduce duration by about 1–1.5 days. However, heterogeneity across preparations and doses makes firm conclusions difficult.

Evidence-Based Uses

  • Prevention of upper respiratory infections (colds)
  • Reduced duration and severity of cold symptoms

How to Use

Standardized E. purpurea extract (at least 4% echinacoside): 400–900 mg 3 times daily at first signs of illness, for 7–10 days. Continuous use not well-supported; consider intermittent use during cold season.

⚠️ Cautions & Interactions

Avoid in autoimmune conditions (lupus, MS, rheumatoid arthritis) and in those on immunosuppressants. Rare allergic reactions, more common in those with ragweed or daisy allergies.

Research References

Echinacea for preventing and treating the common cold (Cochrane review)

Karsch-Völk M, Barrett B, Kiefer D et al. · Cochrane Database of Systematic Reviews (2015) · PMID: 25766897

immunecoldrespiratoryprevention
🔬

Zinc Acetate / Zinc Gluconate Lozenges

Meta-analysis confirms zinc lozenges shorten cold duration by ~33%

Moderate Evidence

Zinc ions released from lozenges into the oral/nasal mucosa appear to inhibit rhinovirus replication and reduce local inflammation. A 2015 meta-analysis of 13 placebo-controlled trials found zinc acetate lozenges reduced cold duration by 42% and zinc gluconate lozenges by 20%.

Evidence-Based Uses

  • Reducing duration of the common cold
  • Reducing severity of cold symptoms

How to Use

Zinc acetate lozenges (13.3 mg) or zinc gluconate lozenges (≥13 mg), started within 24 hours of symptom onset, taken every 2–3 hours while awake. Do not use intranasal zinc sprays (associated with permanent anosmia).

⚠️ Cautions & Interactions

Intranasal zinc sprays are NOT safe and have caused permanent loss of smell. Oral lozenges only. High doses (>40 mg/day long-term) can cause copper deficiency. Not for prevention—only treatment.

Research References

Zinc acetate lozenges may improve the recovery rate of common cold patients: an individual patient data meta-analysis

Hemilä H, Fitzgerald JT, Petrus EJ, Prasad A · Open Respiratory Medicine Journal (2017) · PMID: 29209441

immunecoldzincrespiratoryantiviral

Our Evidence Standard

What we include

Only remedies with at least one Cochrane systematic review, high-quality meta-analysis, or multiple independent RCTs in peer-reviewed journals. We require human trials, not animal or in-vitro studies alone.

What we exclude

We do not include remedies with only anecdotal support, single small trials, or purely traditional use without clinical validation. Essential oils used aromatically or topically are not included here as evidence for systemic effects is insufficient.

Disclaimer

This information is educational and not a substitute for professional medical advice. Drug-herb interactions and individual health factors can significantly alter safety and efficacy. Always inform your healthcare provider of any supplements you take.